PriMera Scientific Surgical Research and Practice (ISSN: 2836-0028)

Case Study

Volume 6 Issue 6

The importance of Microbiome to Overall Health: Integrating Case Studies into improvement of Health and wellness

Christina Rahm*

November 26, 2025

View PDF

Abstract

The human microbiome encompasses a vast community of microorganisms that reside on and inside the human body and play a vital role in promoting health and wellbeing. The microbiome aids in the digestive process metabolic functions, boosts immunity, and promotes mental health via pathways such as the gut-brain axis. On this note, any disruptions in the microbial imbalance, however, which is also referred to as dysbiosis, are associated with disorders like attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD) and Alzheimer’s disease. This research paper explores the role of the microbiome in human health and well-being by integrating the case study findings with existing research to ascertain the therapeutic implications of microbiome-targeted interventions. The case studies involved here highlight the impact of proprietary blends, probiotic uses, and dietary modifications to help enhance emotional regulation, promote the sleep process, ability to focus, and the overall cognitive performance of patients with Alzheimer’s, attention deficit hyperactivity disorder (ADHD), and autism spectrum disorder (ASD). For example, the mini-mental status exam scores were shown to improve among Alzheimer’s patients following the provision of microbiome-targeted therapies, which reflect better cognitive health and overall individual performance. The paper seeks to advocate for a need to increase access to microbiome-based interventions and policy adoption to promote their use in supporting healthcare for various patients. By leveraging the advancing findings in microbiome research today, it is possible to revolutionize treatment for complex disorders and promote the health and wellbeing of patient populations.

References

  1. Aggarwal N., et al. “Microbiome and Human Health: Current Understanding, Engineering, and Enabling Technologies”. Chemical Reviews 123.1 (2022): 31-72.
  2. Anumudu CK, Miri T and Onyeaka H. “Multifunctional Applications of Lactic Acid Bacteria: Enhancing Safety, Quality, and Nutritional Value in Foods and Fermented Beverages”. Foods 13.23 (2023): 3714.
  3. Bear TLK., et al. “The Role of the Gut Microbiota in Dietary Interventions for Depression and Anxiety”. Advances in nutrition (Bethesda, Md.) 11.4 (2020): 890-907.
  4. Bemark M., et al. “Gut-associated lymphoid tissue: a microbiota-driven hub of B cell immunity”. Trends in immunology 45.3 (2024): 211-223.
  5. Boscaini S., et al. “Microbiota and body weight control: Weight Watchers within?”. Molecular Metabolism 57 (2022): 101427.
  6. Checa-Ros A., et al. “Current Evidence on the Role of the Gut Microbiome in ADHD Pathophysiology and Therapeutic Implications”. Nutrients 13.1 (2021): 249.
  7. Dicks LMT. “Gut Bacteria and Neurotransmitters”. Microorganisms 10.9 (2022): 1838.
  8. Dupont HL., et al. “The Intestinal Microbiome in Human Health and Disease”. Transactions of the American Clinical and Climatological Association 131 (2020): 178-197.
  9. Geng H., et al. “Enteric Nervous System: The Bridge Between the Gut Microbiota and Neurological Disorders”. Frontiers in Aging Neuroscience 14 (2022): 810483.
  10. Hou K., et al. “Microbiota in Health and Diseases”. Signal Transduction and Targeted Therapy 7.1 (2022): 135.
  11. Kim H and Shim O. “Gut microbiota affects brain development and behavior”. Clinical and Experimental Pediatrics 66.7 (2022): 274-280.
  12. Kogut MH, Lee A and Santin E. “Microbiome and pathogen interaction with the immune system”. Poultry Science 99.4 (2020): 1906-1913.
  13. Kowalski K and Mulak A. “Brain-Gut-Microbiota Axis in Alzheimer's Disease”. Journal of neurogastroenterology and motility 25.1 (2019): 48-60.
  14. Lu S., et al. “The communication mechanism of the gut-brain axis and its effect on central nervous system diseases: A systematic review”. Biomedicine & Pharmacotherapy 178 (2024): 117207.
  15. Markowiak-Kopeć P and Śliżewska K. “The Effect of Probiotics on the Production of Short-Chain Fatty Acids by Human Intestinal Microbiome”. Nutrients 12.4 (2020): 1107.
  16. Martinez JE., et al. “Unhealthy Lifestyle and Gut Dysbiosis: A Better Understanding of the Effects of Poor Diet and Nicotine on the Intestinal Microbiome”. Frontiers in endocrinology 12 (2021): 667066.
  17. Mihailovich M., et al. “The Microbiome-Genetics Axis in Autism Spectrum Disorders: A Probiotic Perspective”. International Journal of Molecular Sciences 25.22 (2023): 12407.
  18. Mhanna A., et al. “The correlation between gut microbiota and neurotransmitters and mental disorders: A narrative review”. Medicine 103.5 (2023): e37114.
  19. Noor J., et al. “Exploring the Impact of the Gut Microbiome on Obesity and Weight Loss: A Review Article”. Cureus 15.6 (2023): e40948.
  20. Oliphant K and Allen-Vercoe E. “Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health”. Microbiome 7 (2019): 91.
  21. O'Riordan KJ., et al. “Short chain fatty acids: Microbial metabolites for gut-brain axis signaling”. Molecular and Cellular Endocrinology 546 (2022): 111572.
  22. Postan M and Rottenberg ME. “Editorial: Neurotropism of Parasites and the Immune Responses”. Frontiers in Immunology 12 (2021): 775666.
  23. Ruan W., et al. “Healthy Human Gastrointestinal Microbiome: Composition and Function After a Decade of Exploration”. Digestive Diseases and Sciences 65.3 (2020): 695-705.
  24. Ruigrok RAAA, Weersma RK and Vich Vila A. “The emerging role of the small intestinal microbiota in human Health and disease”. Gut Microbes 15.1 (2023): 2201155.
  25. Suganya K and Koo B. “Gut-Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and Immune Pathways to Improve Brain Functions”. International Journal of Molecular Sciences 21.20 (2020): 7551.
  26. Taniya MA., et al. “Role of Gut Microbiome in Autism Spectrum Disorder and Its Therapeutic Regulation”. Frontiers in cellular and infection microbiology 12 (2022): 915701.
  27. Toader C., et al. “Mind, Mood, and Microbiota—Gut-Brain Axis in Psychiatric Disorders”. International Journal of Molecular Sciences 25.6 (2023): 3340.
  28. Verma A, Inslicht SS and Bhargava A. “Gut-Brain Axis: Role of Microbiome, Metabolomics, Hormones, and Stress in Mental Health Disorders”. Cells 13.17 (2023): 1436.
  29. Wasén C., et al. “Bacteroidota inhibits microglia clearance of amyloid-beta and promotes plaque deposition in Alzheimer’s disease mouse models”. Nature Communications 15.1 (2024): 1-12.
  30. Yarahmadi A., et al. “Understanding the complex function of gut microbiota: its impact on the pathogenesis of obesity and beyond: a comprehensive review”. Diabetol Metab Syndr 16 (2024): 308.